Parallax Volatility Advisers, L.P. Jazz Pharmaceuticals PLC Transaction History

Parallax Volatility Advisers, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$125.55 - $144.48 $262,022 - $301,529	-2,087 Reduced 99.33%	14 $2,000
Q1 2019 May 15, 2019	SELL	$121.81 - $142.95 $6.39 Million - $7.5 Million	-52,466 Reduced 96.15%	2,101 $300,000
Q4 2018 Feb 14, 2019	BUY	$115.94 - $166.74 $4.9 Million - $7.05 Million	42,292 Added 344.54%	54,567 $6.76 Million
Q3 2018 Nov 14, 2018	BUY	$161.01 - $180.57 $1.98 Million - $2.22 Million	12,275 New	12,275 $2.06 Million
Q1 2018 May 15, 2018	SELL	$135.59 - $157.16 $1.66 Million - $1.92 Million	-12,246 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$131.06 - $150.39 $565,917 - $649,384	4,318 Added 54.47%	12,246 $1.65 Million
Q3 2017 Nov 14, 2017	BUY	$142.62 - $155.6 $1.13 Million - $1.23 Million	7,928	7,928 $1.16 Million

490

57M

155K

152K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $6.95B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.